These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8404478)

  • 1. [Guidelines for substitution therapy with thrombocytes].
    Bux J; Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1993 Sep; 118(38):1367-70. PubMed ID: 8404478
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients.
    Cid J; Lozano M
    Transfusion; 2005 Mar; 45(3):453; author reply 453-4. PubMed ID: 15752167
    [No Abstract]   [Full Text] [Related]  

  • 4. How I do it: platelet support for refractory patients.
    Dzik S
    Transfusion; 2007 Mar; 47(3):374-8. PubMed ID: 17319815
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion of platelets and plasma products.
    Menitove JE; Aster RH
    Clin Haematol; 1983 Feb; 12(1):239-66. PubMed ID: 6340882
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic factors in reactions to blood transfusions.
    McLeod BC
    Heart Lung; 1980; 9(4):675-81. PubMed ID: 6773907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet antibodies: their detection and significance.
    Harmon JA; Miller WV
    Am J Med Technol; 1981 Oct; 47(10):797-802. PubMed ID: 7036742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet pool versus single platelet donor].
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):293-319. PubMed ID: 2832927
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloantibodies and platelet destruction.
    Klein CA; Blajchman MA
    Semin Thromb Hemost; 1982 Apr; 8(2):105-15. PubMed ID: 7043738
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombocyte substitution. I. Indications and clinical use of thrombocyte transfusion].
    Anders O; Preussner S; Konrad H
    Z Gesamte Inn Med; 1986 Nov; 41(21):592-5. PubMed ID: 3825211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 13. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfusion strategy in substitution with thrombocytes and granulocytes].
    Wiesneth M
    Beitr Infusionther Klin Ernahr; 1987; 18():108-14. PubMed ID: 2830874
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiplatelet antibody].
    Shibata Y; Yamanaka M
    Rinsho Byori; 1985 Jul; 33(7):734-41. PubMed ID: 3934431
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.
    Lozano M; Cid J
    Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors affecting posttransfusion platelet efficiency "close relationship between patient and product"].
    Sensebé L
    Transfus Clin Biol; 2007 May; 14(1):90-3. PubMed ID: 17513157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA, ABO and Rh antigens in blood donors with and without surface antigen for hepatitis B (HBsAg) (author's transl)].
    Dorlhiac P; Fuentes C; de la Fuente C; Velasco M
    Rev Med Chil; 1978 Oct; 106(10):755-7. PubMed ID: 105389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.